MARKET

TCDA

TCDA

Tricida
NASDAQ

Real-time Quotes | Nasdaq Last Sale

31.07
+0.61
+2.00%
After Hours: 31.07 0 0.00% 16:00 10/11 EDT
OPEN
30.99
PREV CLOSE
30.46
HIGH
32.21
LOW
30.60
VOLUME
179.74K
TURNOVER
--
52 WEEK HIGH
42.80
52 WEEK LOW
19.43
MARKET CAP
1.21B
P/E (TTM)
-10.4867
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TCDA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

TCDA News

  • Tricida Announced Manufacturing And Commercial Supply Agreement With Patheon
  • Benzinga.3d ago
  • Tricida to Host Investor Day on October 15, 2019
  • Business Wire.10/04 15:24
  • Tricida Announces Multiple Data Presentations on Metabolic Acidosis to be Given at ASN Kidney Week 2019
  • Business Wire.10/02 12:30
  • Our Roundtable Experts Pick 15 Biotech Stocks
  • marketwatch.com.09/30 13:46

More

Industry

Biotechnology & Medical Research
+0.89%
Pharmaceuticals & Medical Research
+0.89%

Hot Stocks

Name
Price
%Change

About TCDA

Tricida, Inc. is a late-stage pharmaceutical company focused on the discovery and clinical development of non-absorbed therapeutics to address renal, metabolic and cardiovascular disease. The Company's lead program, TRC101 is a treatment for chronic kidney disease (CKD). The Company is engaged in developing a non-absorbed drug to enable safety and efficacy for chronic treatment of CKD patients. The TRC101 drug acts in the gastrointestinal tract and clears the human body through the digestive system, by preventing degradation and systemic uptake.
More

Webull offers Tricida Inc (TCDA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.